Liu, Li et al
"The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4." Clinical Cancer Research
21.7
(2015):
1639-1651.
Web. 21 Jan. 2021.
